4 results
Approved WMOCompleted
Investigating the bioequivalence of the new formulation of escitalopram.
Approved WMOCompleted
Investigating the bioequivalence of the new formulation of escitalopram.
Approved WMOCompleted
The primary objective of this study is to demonstrate the efficacy of the combination therapy of aliskiren (150 mg and 300 mg) and HCTZ 25 mg in hypertensive patients who do not show sufficient blood pressure response to a 4-week treatment of HCTZ…
Approved WMOCompleted
To investigate if jerks and psychiatric disorders in patients with dystonia are associated with a hyperdopaminergic/ hyposerotonergic system and whether reversal of a hyposerotonergic state has a therapeutic effect.